|
L Capital firm bought by Novartis
By Gali Weinreb
Jun 4, 2008, 14:40
US-Israeli venture capital fund L Capital Partners, founded by managing partner Jonathan Leitersdorf, has sold portfolio company Protez Pharmaceuticals Inc. to Swiss giant Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ) for up to $400 million. $100 million will be paid immediately and an additional $300 million will be paid upon reaching milestones and in royalties on successful products.
Protez is a US start-up that develops new antibodies for hospital-based infections. The company has raised $23 million to date; investors will make a four-fold return on their investments, and up to a 16-fold return if all goes well.
Published by Globes [online], Israel business news - www.globes-online.com - on June 4, 2008
STEP Strategy
Advisors
www.STEPStrategy.net
(310) 282 - 0800
BACK to
STEP News
|